Similar articles

• Femoral-artery infusion of prostaglandin E 1 in severe peripheral vascular disease.

  Carlson LA, Eriksson I. Carlson LA, et al. Lancet. 1973 Jan 20;1(7795):155-6. doi: 10.1016/s0140-6736(73)90233-x. Lancet. 1973. PMID: 4118503 No abstract available.
• Peripheral vascular responses in the limbs. Is there a difference between the peripheral vascular responses of the upper and lower limbs?

  Walkey FA. Walkey FA. Angiology. 1978 Jan;29(1):76-9. doi: 10.1177/000331977802900111. Angiology. 1978. PMID: 343653 Review. No abstract available.
• Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease.

  Sinzinger H, Virgolini I, O'Grady J. Sinzinger H, et al. Prog Clin Biol Res. 1989;301:85-96. Prog Clin Biol Res. 1989. PMID: 2477859 Review. No abstract available.
• The action of tetranicotinoylfructose in peripheral vascular disease.

  Andrews G, Judge TG, Walkey F. Andrews G, et al. Practitioner. 1973 Jul;211(261):83-5. Practitioner. 1973. PMID: 4580277 Clinical Trial. No abstract available.
• A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders.

  Mizushima Y, Shiokawa Y, Homma M, Kashiwazaki S, Ichikawa Y, Hashimoto H, Sakuma A. Mizushima Y, et al. J Rheumatol. 1987 Feb;14(1):97-101. J Rheumatol. 1987. PMID: 3553591 Clinical Trial.